Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Exp Dermatol ; 35(1): 31-5, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19549242

ABSTRACT

BACKGROUND: The association between diet and acne vulgaris has long been suggested but remains unproven in western medicine. In contrast, the diet-acne relationship is considered important in traditional Chinese medicine (TCM). Aim. To investigate the association between diet and acne, using a TCM approach. METHODS: Using a cross-sectional study of 322 entrants to a university in Hong Kong, China, we examined the participants' clinical severity of acne using the Global Acne Grading System and the participants' yin and yang scores using a quantitative method. We then divided them into two groups, a yin-predominant group (yin-PG) and a yang-predominant group (yang-PG) before the diet-acne relationship was investigated. RESULTS: In total, 82 (25.2%) participants were in the clinical acne group and 240 (74.5%) were in the reference group. There were 155 (48.1%) participants in the yin-PG and 167 (51.9%) in the yang-PG group. No association of diet and acne was found when the participants were considered as a homogenous group. In yin-PG, intake of foods from street stalls (P = 0.04) was significantly associated with a lower incidence of acne. In yang-PG, the intake of desserts (P = 0.04) and fresh fruit juices (P = 0.02) was significantly associated with a higher incidence of acne, whereas the intake of dairy and soy products (P = 0.04) was significantly associated with a lower incidence of acne. CONCLUSIONS: The application of a TCM approach led to the detection of significant associations between diet and the incidence of acne.


Subject(s)
Acne Vulgaris/etiology , Diet/adverse effects , Medicine, Chinese Traditional/methods , Yin-Yang , Cross-Sectional Studies , Feeding Behavior , Female , Hong Kong , Humans , Male , Surveys and Questionnaires , Young Adult
2.
Clin Exp Dermatol ; 35(1): 16-21, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19486044

ABSTRACT

BACKGROUND: Data are lacking on the prevalence of acne, its effects on quality of life (QOL) and the treatment usage among Chinese patients in late adolescence. AIM: To derive data about the prevalence and predictive factors of acne, the disability caused by acne and choice of treatment used by Chinese late adolescents in Hong Kong. METHODS: This was a cross-sectional study of a random sample of 389 entrants in a university in Hong Kong, using the Global Acne Grading System (GAGS) to measure the clinical severity of acne and the Cardiff Acne Disability Index (CADI) to measure QOL. RESULTS: The response rate was 99.3%. The prevalence of acne was of 81.5% (95% CI 77.6-85.4%) and coexisted with a high frequency of acne disability at a rate of 81.8% (95% CI 78.1-85.6%). Assessment of the clinical severity of acne did not correlate strongly with the effect on QOL (gamma(s) = 0.445, P < 0.001). Over the previous 6 months, 30.3% of subjects had used topical treatments, 3.9% had taken systemic conventional western drugs and 3.2% of the subjects had used traditional Chinese medicine. Multivariate logistic regression was used to explore the predictive factors for acne disability. Female gender (P = 0.002), higher GAGS score (P < 0.001), higher perceived stress (P = 0.01) and willingness to pay Hong Kong$15,000 (970 pounds) for a hypothetical permanent cure (P = 0.03) were positive predictors. CONCLUSIONS: Acne is prevalent in Hong Kong and has considerable psychological effects. The association between clinical severity and impaired QOL is not strong.


Subject(s)
Acne Vulgaris/psychology , Quality of Life/psychology , Acne Vulgaris/epidemiology , Adolescent , China , Cross-Sectional Studies , Female , Health Knowledge, Attitudes, Practice , Hong Kong/epidemiology , Humans , Male , Patient Acceptance of Health Care , Prevalence , Severity of Illness Index , Surveys and Questionnaires , Young Adult
3.
Cochrane Database Syst Rev ; (2): CD005068, 2007 Apr 18.
Article in English | MEDLINE | ID: mdl-17443568

ABSTRACT

BACKGROUND: Pityriasis rosea is a scaly rash that mainly affects young adults. It can be very itchy but most people recover within 2 to 12 weeks. OBJECTIVES: To assess the effects of interventions for pityriasis rosea. SEARCH STRATEGY: We searched the Cochrane Skin Group Specialised Register (December 2004), the Cochrane Central Register of Controlled Clinical Trials in The Cochrane Library (Issue 4, 2004), MEDLINE (1966 to January 2005), EMBASE (1976 to January 2005), LILACS (1982 to January 2005), BIOSIS Preview (1980 to June 2002), and ongoing trials databases. We scanned bibliographies of published studies, abstracts from dermatology conference proceedings, corresponded with trialists and contacted the pharmaceutical industry. SELECTION CRITERIA: Randomised controlled trials evaluating interventions for pityriasis rosea. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. We contacted study authors to retrieve missing data. MAIN RESULTS: Three trials involving 148 people were included. One poor quality trial (23 people), compared intravenous glycyrrhizin and intravenous procaine. It found no significant difference between the two interventions for treating symptoms and rash. One fair quality trial (85 people), compared the oral antihistamine dexchlorpheniramine (4 mg), the oral steroid betamethasone (500 mcg), and a combination of betamethasone (250 mcg) and dexchlorpheniramine (2 mg). It found no significant difference in itch resolution at two weeks, as rated by the participants, between dexchlorpheniramine and betamethasone, and the combination of dexchlorpheniramine and betamethasone. However, both dexchlorpheniramine and betamethasone alone seem to be better at clearing rash than the combination of dexchlorpheniramine and betamethasone. These interventions were not compared with placebo. The small good quality trial (40 people) that compared oral erythromycin and placebo found that erythromycin was more effective than placebo in terms of rash improvement, as rated by the trialists, after two weeks (RR 13.00; 95% CI 1.91 to 88.64). It was also more effective in decreasing the itch score (difference of 3.95 points, 95% CI 3.37 to 4.53). No serious adverse effects were reported for the interventions. Two out of 17 people on oral erythromycin and 1 out of 17 on placebo reported minor gastrointestinal upset. AUTHORS' CONCLUSIONS: We found inadequate evidence for efficacy for most treatments for pityriasis rosea. Oral erythromycin may be effective in treating the rash and decreasing the itch. However, this result should be treated with caution since it comes from only one small RCT. More research is necessary to evaluate the efficacy of erythromycin and other treatments.


Subject(s)
Pityriasis Rosea/therapy , Adult , Anti-Infective Agents/therapeutic use , Erythromycin/therapeutic use , Female , Glycyrrhizic Acid/therapeutic use , Histamine H1 Antagonists/therapeutic use , Humans , Male , Pityriasis Rosea/drug therapy , Randomized Controlled Trials as Topic
4.
J Eur Acad Dermatol Venereol ; 20(6): 667-71, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16836493

ABSTRACT

BACKGROUND: Herpesvirus-like particles have been reported to be detectable by electron microscopy in lesional biopsy of patients with pityriasis rosea (PR). We report a study investigating the association of PR with human herpesvirus-8 (HHV-8) infection. METHODS: Our setting is a teaching clinic affiliated to a university. We recruited eight patients aged 28-47 years (mean: 34.5 years) diagnosed with PR during a one-year period. We collected acute blood specimens at presentation and convalescent blood specimens three to four weeks later. We also collected skin scrapings from the herald patch where present and from truncal secondary lesions. RESULTS: We detected HHV-8 DNA by a nested PCR (polymerase chain reaction) targeting, respectively, a 233-bp and a 160-bp fragment of ORF 26. PCR for HHV-8 DNA was negative in the peripheral blood mononuclear cells and plasma of acute and convalescent specimens of all patients, and negative in all skin scrapings. We detected anti-HHV-8 IgG and IgM antibodies by the indirect immunofluorescence. Four patients had IgG antibodies against HHV-8, but with no significant rise of titre. None were positive for anti-HHV-8 IgM antibody. CONCLUSION: We conclude that PR is not associated with HHV-8 infection.


Subject(s)
DNA, Viral/blood , Herpesvirus 8, Human/genetics , Leukocytes, Mononuclear/metabolism , Pityriasis Rosea/blood , Pityriasis Rosea/virology , Adult , DNA, Viral/metabolism , Female , Herpesviridae Infections/blood , Herpesviridae Infections/complications , Herpesvirus 8, Human/immunology , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Pityriasis Rosea/complications , Polymerase Chain Reaction
6.
Clin Exp Dermatol ; 29(6): 597-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15550130

ABSTRACT

Previous studies on the association of smoking with acne vulgaris have reported conflicting results. The objective of this study was to investigate such an association. Our setting was three primary care practices in Hong Kong and one primary care practice in India. Patient characteristics in all four practices are similar. All medical records in these practices incorporate a section in which the smoking habits of each patient is routinely documented. We searched our database and retrieved 632 records of patients with acne seen in the previous 5 years. We also retrieved 632 records of age- and sex-matched controls. Fifty-three out of 379 male patients with acne and 25 out of 379 male controls were smokers (P = 0.001; OR, 2.3; 95% CI, 1.4-3.8). Six out of 253 female patients with acne and three out of 253 female controls were smokers (OR, 2.0; 95% CI, 0.5-9.4). We conclude that smoking is likely to bear a positive correlation with acne for men. Our numbers are too small for a definite conclusion to be drawn for females.


Subject(s)
Acne Vulgaris/etiology , Smoking/adverse effects , Adult , Case-Control Studies , Female , Humans , Male , Primary Health Care , Retrospective Studies , Risk Factors , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...